Patti Connolly, M.S.
Pearl IRB proudly announces the hiring of Patti Connolly, M.S. as Director of Clinical Services. Connolly brings over 30 years of experience in medical research across academic and industry settings, with 10 years dedicated directly to product development, clinical research, and regulatory affairs. Her extensive experience includes managing successful medical device in vitro diagnostics design development projects, clinical trial design and execution, IRB submissions, as well as CAP/CLIA/GXP compliance.
Prior to joining Pearl IRB, Connolly was a founding member of MiraVista Diagnostics, a high-growth company involved in the development of innovative diagnostic test system technologies for infectious diseases. Through her leadership, Connolly bolstered growth of the company from a start-up concept to a well-established, profitable life science organization. As Director of Clinical Services, Connolly will lead the clinical research team and oversee Pearl Pathways’ clinical research projects, and support the AAHRPP accredited Independent Institutional Review Board, Pearl IRB.
Diana Caldwell, President and CEO shares, “Patti brings leadership experience and an infectious passion for the patient to our company. She possesses profound expertise in the areas of product development, clinical research, regulatory and in vitro diagnostic device technologies. She is a results-driven leader who develops cross-functional teams with a winning attitude. We are extremely excited to have Patti join the ranks of our management team.”
You can learn more about Patti in the full press release.